Steroid Resistance in Pediatric Immune Thrombocytopenic Purpura

Lymphocyte Counts in Immune Thrombocytopenic Purpura

NCT03244410 ·Status: UNKNOWN

Eltrombopag in Chronic ITP

NCT04102033 ·Status: UNKNOWN ·Phase: PHASE4

Prognostic Value of CD Markers in Immune Thrombocytopenic Purpura

NCT04311593 ·Status: UNKNOWN

Association of Platelet Parameters With Bleeding Severity in Children With ITP

NCT03810352 ·Status: COMPLETED

Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)

NCT06168851 ·Status: RECRUITING ·Phase: PHASE2

Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D

NCT00128882 ·Status: COMPLETED ·Phase: PHASE2

Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura

NCT00486421 ·Status: COMPLETED ·Phase: EARLY_PHASE1

An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers

NCT00005570 ·Status: COMPLETED

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

NCT03939637 ·Status: COMPLETED ·Phase: PHASE3

Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients

NCT01730352 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Assessment of Quality of Life of Children With Chronic Idiopathic Thrombocytopenic Purpura (Kid's ITP Tools)

NCT03123497 ·Status: UNKNOWN

Childhood Reactive Thrombocytosis

NCT01230528 ·Status: COMPLETED

Outcome Study of Conventional Steroids Vs. Steroids Combined with Mycopehnolate in Newly Diagnosed Immune Thrombocytopenia Purpura.

NCT06288932 ·Status: COMPLETED ·Phase: PHASE3

Research of Predictive Factors to Immune Thrombopenic Purpura

NCT01648556 ·Status: COMPLETED ·Phase: NA

Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)

NCT00713193 ·Status: COMPLETED ·Phase: PHASE3

Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

NCT05846529 ·Status: UNKNOWN

A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia Purpura

NCT01071954 ·Status: COMPLETED ·Phase: PHASE3

Triple Therapy in Patients With Idiopathic Thrombocytopenic Purpura : What is Behind?

NCT04128358 ·Status: UNKNOWN ·Phase: NA

Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)

NCT05263193 ·Status: COMPLETED

Study of the Role of Regulator T Cells in the Pathophysiology of Childhood Henoch Schönlein Purpura

NCT02317133 ·Status: COMPLETED

Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.

NCT01520909 ·Status: COMPLETED ·Phase: PHASE3

A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP.

NCT00376077 ·Status: COMPLETED ·Phase: PHASE3

"Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"

NCT07014904 ·Status: NOT_YET_RECRUITING

Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects

NCT00515203 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy

NCT04113915 ·Status: UNKNOWN